Mich. Panel: Gilead Immune From Recalled COVID Drug Suit

By Carolyn Muyskens

Gilead Sciences Inc. has escaped a lawsuit pinning a man's strokes on doses of an antiviral COVID-19 medication that were later recalled, with a Michigan state appeals court finding that the company is protected by a public health law's liability shield.

 Opinion attached | Read full article » | Save to favorites »